For the Inventor, By the Inventor

Enter assignee name

Alameda, CA, United States of America

Xenogen Corporation

USPTO Granted Patents = 67

% Expired Patents = 19.4

EPO Patents = 9

Trademarks = 3

Forward Citations = 749

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Bradley W Rice (37 out of 42 patents)

Michael D Cable (27 out of 30 patents)

David G Nilson (22 out of 29 patents)

4. Tamara Troy (11 out of 17 patents)

5. Daniel G Stearns (11 out of 34 patents)

6. Pamela R Contag (11 out of 25 patents)

7. Michael Bo Nelson (10 out of 10 patents)

8. Brad Rice (6 out of 6 patents)

9. Anthony Purchio (6 out of 6 patents)

10. Heng Xu (5 out of 5 patents)

11. Kevin P Francis (4 out of 5 patents)

12. Chaincy Kuo (4 out of 4 patents)

13. Kevin A Nawotka (3 out of 3 patents)

14. Kevin Kearney (3 out of 6 patents)

15. David N Sprague (3 out of 3 patents)

Core Competencies:

Spectral Unmixing

In-Vivo Imaging

Fluorescence Guided Surgery

3-D Imaging

Optical Tissue Properties

Biodetectors

Structured Light Imaging

Transgenic Mice

Anesthesia Delivery

Imaging Apparatus

Tissue Phantom Calibration

Illumination Systems

67 patents: Sort by Forward Citations

1. 11730370 - Spectral unmixing for in-vivo imaging (2023-08-22),

2. 10775308 - Apparatus and methods for determining optical tissue properties (2020-09-15),

3. 10335038 - Spectral unmixing for in-vivo imaging (2019-07-02),

4. 9080977 - Apparatus and methods for fluorescence guided surgery (2015-07-14),

5. 9008758 - Multi-mode internal imaging (2015-04-14),

6. 8909326 - Method and apparatus for 3-D imaging of internal light sources (2014-12-09),

7. 8825140 - Imaging system (2014-09-02),

8. 8734342 - Graphical user interface for in-vivo imaging (2014-05-27),

9. 8372597 - Methods of screening for introduction of DNA into a target cell (2013-02-12),

10. 8349602 - Biodetectors targeted to specific ligands (2013-01-08),

11. 8279334 - Structured light imaging apparatus (2012-10-02),

12. 8180435 - Method and apparatus for determining target depth, brightness and size within a body region (2012-05-15),

13. 8044996 - Surface construction using combined photographic and structured light information (2011-10-25),

14. 7949383 - Imaging apparatus with selectable moveable stage (2011-05-24),

15. 7881773 - Multi-mode internal imaging (2011-02-01),

Company Overview

Xenogen Corporation, based in Alameda, CA, specializes in advanced in-vivo imaging technologies that enhance biomedical research and clinical applications. The company focuses on innovative techniques such as spectral unmixing and fluorescence-guided surgery, which facilitate real-time visualization of biological processes. Their expertise extends to 3-D imaging, optical tissue properties, and the development of biodetectors, leveraging transgenic mice models to advance scientific understanding and improve therapeutic outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

67 Patents

#8 in Alameda, CA

#1,270 in California

#5,461 in US

#11,040 in the World

Alameda, CA, United States of America

Xenogen Corporation

Forward Citations = 749

42 inventors:

Bradley W Rice (37 out of 42 patents)

Michael D Cable (27 out of 30 patents)

David G Nilson (22 out of 29 patents)

4. Tamara Troy (11 out of 17 patents)

5. Daniel G Stearns (11 out of 34 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xenogen Corporation. Retrieved from https://idiyas.com/company/xenogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…